ESR1 and breast cancer: Unlike the broad range of molecular subtypes represented in the in vitro experiments, this in vivo study was limited to evaluating the efficacy of SSA for the prevention of the low grade, estrogen receptor expressing mammary tumors that were induced by MNU [60,61].